DOP083 Prospective, longitudinal observational study in therapeutic management of mild to moderate ulcerative colitis (OPTIMUM): follow-up at one year

to reveal gaps between the evidence and practice in order to begin closing the gaps. Methods: To gauge practice patterns, 6 treatment-scenario statements were developed, pertaining to anti-tumor necrosis factor (TNF) therapy, definitions of treatment failure, the use of drug levels, and long-term risks. Gastroenterologists (N = 17,005 globally) were asked via emailed survey to vote on each statement, using a Likert scale of acceptance or rejection. All survey respondents (SRs; n = 218) were in practice, and 73.9% reported spending 25% of their time managing IBD patients. While the survey was conducted for 6 weeks, the GLs reviewed the medical literature related to each statement and then voted on the statements, using the same Likert scale as the survey. The survey results and the GL voting were then compared and analysed to identify gaps in evidence-based practice in IBD management. Results: Voting results from 2 of the 6 statements are shown here (Figs 1, 2) and align with the other 4 statements. Figure 1 shows more than 40% of SRs rejected the statement; the majority of GLs accepted it.